Virginie Nourtier

Immune Checkpoint Blockade, Immunogenic Chemotherapy or IFN-α Blockade Boost the Local and Abscopal Effects of Oncolytic Virotherapy

Laetitia Fend, Takahiro Yamazaki, Christelle Remy et al. · Cancer Research · 2017 · 126 citations

Medicine, Immunology, Oncology +17

Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLC

Caroline Tosch, Bérangère Bastien, Luc Barraud et al. · Journal for ImmunoTherapy of Cancer · 2017 · 66 citations · Full text

Life Sciences, Immunology, Oncology +17

Sequential administration of MVA-based vaccines and PD-1/PD-L1-blocking antibodies confers measurable benefits on tumor growth and survival: Preclinical studies with MVA-βGal and MVA-MUC1 (TG4010) in a murine tumor model

Christelle Remy‐Ziller, Christine Thioudellet, Julie Hortelano et al. · Human Vaccines & Immunotherapeutics · 2017 · 34 citations · Full text

Life Sciences, Immunology, Oncology +17

Preclinical Evaluation of the Oncolytic Vaccinia Virus TG6002 by Translational Research on Canine Breast Cancer

Jérémy Béguin, Johann Foloppe, Christelle Maurey et al. · Molecular Therapy — Oncolytics · 2020 · 27 citations · Full text

Medicine, Oncology, Pharmacology +16

By Binding CD80 and CD86, the Vaccinia Virus M2 Protein Blocks Their Interactions with both CD28 and CTLA4 and Potentiates CD80 Binding to PD-L1

Patricia Kleinpeter, Christelle Remy‐Ziller, Eline Winter et al. · Journal of Virology · 2019 · 25 citations · Full text

Life Sciences, Immunology, Molecular Biology +17